Advanced IVF, IUI & ICSI treatments with highest success rates — compassionate care for every step of your fertility journey.
State-of-the-art IVF lab, experienced embryologists and personalised protocols for the best possible outcomes.
Comprehensive care across pregnancy, fertility and advanced gynaecology — delivered with privacy, safety and compassion.
15+ years of expertise, advanced labs and personalised treatment plans.
Advanced facial & body cosmetic procedures by expert surgeons — natural results, minimal downtime, maximum confidence.
Board-certified surgeons delivering natural, beautiful results with the latest techniques.
Expert reconstructive & plastic surgery for hand, birth deformities, cancer reconstruction and trauma — restoring form and function with precision.
Advanced body contouring, breast surgeries & intimate procedures by expert surgeons — natural results, renewed confidence.
Advanced laser skin treatments, intimate wellness procedures & expert hair restoration — all under one roof.
State-of-the-art laser tech & hair restoration by certified specialists.
Comprehensive fertility, hormonal & genetic diagnostics for females and males — accurate, fast and confidential.
A Pap smear is recommended every 3 years from the age of 21 regardless of sexual activity history. This age group benefits most from early establishment of a regular screening routine before any cellular changes develop.
A Pap smear every 3 years, or combined co-testing with the HPV DNA test every 5 years, is the recommended approach. Co-testing provides the most comprehensive cervical cancer risk assessment currently available.
Women with HIV, a history of cervical abnormalities, immunosuppression, or a previous abnormal Pap smear result require more frequent annual screening regardless of age, as their risk of developing cervical changes is significantly elevated.
Vaccinated women must continue regular Pap smear and HPV DNA screening as the vaccine does not protect against all cancer-causing HPV strains. Vaccination and screening are complementary and both remain essential.
Any woman with a prior abnormal Pap smear result, borderline findings, or detected high-risk HPV infection requires closer monitoring with more frequent screening intervals and possible referral for colposcopy.
Women aged 65 with three consecutive normal results and no history of high-grade abnormalities may discontinue screening on specialist advice. Women who had a hysterectomy for non-cancerous reasons should seek guidance on whether continued screening is required.
Avoid intercourse, vaginal medicines, tampons and douching before the test when advised. Mid-cycle timing often helps improve sample accuracy.
The examination is done in a private setting with dignity and support, usually taking only a few minutes from positioning to sample collection.
A lubricated speculum is gently inserted to view the cervix clearly, allowing the specialist to collect the sample safely and accurately.
A soft brush or spatula collects cervical cells within seconds. Most women feel only mild pressure or brief discomfort.
The sample is processed for Pap smear cytology and/or HPV DNA testing to detect abnormal cells or high-risk viral strains.
Mild spotting can occur briefly and is usually normal. Results are reviewed once available, with clear explanation from your specialist.
Normal results guide future screening timing; abnormal findings may require repeat testing, HPV review or colposcopy for closer assessment.

Identifies pre-cancerous cervical cell changes at the earliest and most treatable stage, long before any symptoms appear and when intervention is simplest, safest, and most clinically effective.

Regular screening has been credited with dramatically reducing cervical cancer death rates in countries where established programmes are in place, making it one of the most life-saving public health tools available.

The HPV DNA test detects the presence of cancer-causing viral strains before any visible cellular abnormality has developed, providing the earliest possible warning of elevated cervical cancer risk.

Pre-cancerous lesions detected through early screening can be treated with simple, minimally invasive procedures that prevent progression to invasive cancer, surgery, chemotherapy, or radiation entirely.

A normal screening result provides clinical certainty and complete peace of mind, confirming low cervical cancer risk and allowing women to continue their lives with full confidence in their health.

Through early-stage detection, screening dramatically reduces the need for intensive treatments such as radical hysterectomy, chemotherapy, and radiation that advanced cervical cancer requires.

Regular screening empowers women to take active, informed control of their long-term reproductive and overall health, making them active participants in their own cancer prevention rather than passive observers.

The cost of regular screening is a small fraction of the financial, physical, and emotional burden of treating advanced cervical cancer, making it one of the most cost-effective healthcare investments available.

Results guide how frequently each individual woman needs to be monitored, with risk-based personalisation ensuring that higher-risk women receive closer surveillance and low-risk women are not over-screened.

Regular screening prompts consistent gynaecological check-ups that often identify other reproductive health concerns early, contributing to comprehensive women's health maintenance beyond cervical cancer prevention alone.























Eggs Successfully Frozen

Vitrification Survival Rate

Years of Experience

Support to Call

A Pap smear examines the physical appearance of cervical cells under a microscope to detect abnormal cellular changes, while the HPV DNA test analyses the genetic material of the virus itself to detect the presence of high-risk HPV strains even before any cellular abnormalities have developed. The HPV DNA test is therefore a more sensitive early-warning tool for cancer risk. The most comprehensive approach is co-testing, using both simultaneously in a single appointment. Your specialist at Galwa Care Hospital will recommend the most appropriate option based on your age, health history, and individual risk profile.
For most women, a Pap smear causes only mild pressure or brief discomfort during cell collection and is not a painful procedure. It is completed within a few minutes in a completely private setting at Galwa Care Hospital. An abnormal result does not mean you have cancer. It means that some cervical cells look different from normal and require further investigation, such as a repeat test, HPV DNA testing, or colposcopy for closer examination. Your specialist will explain exactly what your specific result means and what the recommended next steps are.
Yes, absolutely. The HPV vaccine does not protect against all cancer-causing HPV strains, so regular Pap smear and HPV DNA screening remains essential for all vaccinated women throughout their recommended screening age range. Vaccination and screening are complementary strategies that work together. It is generally recommended to avoid scheduling a Pap smear during menstruation as blood can interfere with accurate cell analysis. Ideally schedule your appointment mid-cycle around 10 to 20 days after your period begins for the most accurate sample collection.
A positive HPV DNA test means a high-risk strain has been detected in your cervical cells. It does not mean cancer is present. The vast majority of HPV infections clear naturally without causing cancer. However, a positive result indicates the need for closer monitoring and your doctor will recommend appropriate follow-up, which may include a repeat test after 12 months, Pap smear co-testing, or colposcopy for direct visual examination of the cervix. Your specialist at Galwa Care Hospital will guide you through every step of the follow-up process with complete clarity and support.
Cervical cancer screening is generally recommended to begin at age 21, or earlier if clinically indicated. Screening may be discontinued at age 65 if the previous three consecutive results have been normal and there is no history of high-grade abnormalities, on the advice of your specialist. To prepare for your appointment, avoid sexual intercourse, vaginal douching, tampons, and vaginal medications for 48 hours before the test. Avoid scheduling during menstruation and aim for the mid-cycle window of 10 to 20 days after your period begins for the most reliable cell sample collection and the most accurate result.